Navigating life together
The following commentary highlights fundamental and commonly accepted practices on the subject matter. The information is intended as a general overview and is for educational
purposes only. This information does not constitute legal advice, which can only be provided by an attorney.
© 2020 MetLife Services and Solutions, LLC. All materials subject to this copyright may be photocopied for the noncommercial purpose of scientific or educational advancement.
Originally published November 2007.
Updated and revised September 2010, June 2014, March 2017 and April 2020.
Expiration date: April 2023.
The content of this Guide is subject to change as new scientific information becomes available.
Educational Objectives
Following this unit of instruction, the practitioner should be able to:
1. Describe the typical early characteristics of early or developing bisphosphonate and other
medication-related jaw necrosis (MRONJ).
2. Interpret the radiographic alterations associated with MRONJ.
3. Understand the three components of an established case of MRONJ.
4. Discuss the criteria-based MRONJ clinical staging system.
5. Understand the chief initiators of MRONJ and the role of prevention strategies concerning this
problem.
6. Appreciate the difficulties involved in the management of all stages of MRONJ.
This article describes the clinical management of Bisphosphonate-Related Osteonecrosis.
Readers should review Part
One:
Bisphosphonate and Other Medication-Related Osteonecrosis:
Background, Incidence and Risk Factors prior to starting this paper.
Accepted Program Provider FAGD/MAGD Credit
11/01/16 - 12/31/20.
ADA CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors,
nor does it imply acceptance of credit hours by boards of dentistry.
MetLife designates this activity for
1.5 continuing education credits
for the review of this Quality Resource Guide and successful completion of the post test.
Fifth Edition
Concerns or complaints
about a CE provider may be directed
to the provider or to ADA CERP at www.ada.org/goto/cerp.
Address comments or questions to:
DentalQuality@metlife.com
MetLife Dental Continuing Education
501 US Hwy 22, Area 3D-309B
Bridgewater, NJ
08807
Cancellation/Refund Policy:
Any participant who is not 100% satisfied with this course
can request a full refund by contacting us.
MetLife is an ADA CERP Recognized Provider.
Quality
Resource Guide
Bisphosphonate Medication-Related Jaw Necrosis
Part Two:
Clinical Management
Author Acknowledgement
JAMES J. SCIUBBA, DMD PHD
The Milton J. Dance Head & Neck Center
The Greater Baltimore Medical Center
Baltimore, Maryland
Professor (Ret) Johns Hopkins Medical Center
Baltimore, Maryland
Dr. Sciubba has no relevant
financial
relationships to disclose.